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Abstract: Purpose: Patients with diastolic dysfunction may have a disproportionate degree of elevation in pulmonary  
pressure, particularly in the elderly. Higher pulmonary vascular resistance in the elderly patients with heart failure   
but preserved ejection fraction suggests that beyond the post-capillary contribution of pulmonary venous congestion, a 
pre-capillary component of pulmonary arterial hypertension occurs. We aim to identify if pulmonary vascular resistance 
in elderly patients with diastolic dysfunction is disproportionately higher than patients with systolic dysfunction   
independent of filling pressures. 
Methods: 389 patients identified retrospectively between 2003- 2010; elderly with preserved ejection fraction, elderly  
with depressed ejection fraction, and primary arterial hypertension who underwent right-heart catheterization at Rush 
University.  
Results: No significant difference in pulmonary vascular resistance between systolic and diastolic dysfunction. The mean 
difference in pulmonary vascular resistance was not statistically significant at 0.40 mmHg·min/l (95% CI -3.03 to 3.83) 
with similar left ventricular filling pressures with mean difference of 3.38 mmHg (95% CI, -1.27 to 8.02). When adjusted 
for filling pressures, there remained no difference in pulmonary vascular resistance for systolic and diastolic dysfunction. 
The mean pulmonary vascular resistance is more elevated in systolic heart failure compared to diastolic heart failure with 
means 3.13 mmHg·min/l and 3.52 mmHg·min/l, respectively. 
Conclusion: There was no other association identified for secondary pulmonary hypertension other than diastolic dysfunc-
tion and chronic venous pulmonary hypertension. Our results argue against any significant arterial remodeling that would 
lead to disproportionate pre-capillary hypertension, and implies that treatment should focus on lowering filling pressure 
rather than treating the pulmonary vascular tree. 
Keywords: Diastolic heart failure, heart failure, preserved left ventricular ejection function, pulmonary hypertension, right 
heart catheterization. 
INTRODUCTION 
  Pulmonary hypertension (PH) is caused by increased 
resistance at one of several sites in the pulmonary circula-
tion, including the heart’s left chambers and valves. The 
pulmonary capillary wedge pressure (PCWP) is evaluated 
during the classification process of PH to identify the etiol-
ogy of PH [1]. PH associated with a normal PCWP is classi-
fied as pre-capillary PH, and PH associated with an elevated 
PCWP is classified as post-capillary PH. There are many 
different etiologies of pulmonary hypertension, but the most 
common is pulmonary venous hypertension owing to left 
heart disease, a type of post-capillary PH [2]. This particular 
form of PH can occur in the setting of elevated left sided 
filling pressures and preserved ejection fraction (EF) [3].   
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Typically, the degree of elevation in pulmonary artery pres-
sure (PAP) is concordant with the degree of elevation in the 
atrial pressure [4]. PH is also reported in patients with dia-
stolic heart failure, but its prevalence and severity are poorly 
defined [2].  
  In congestive heart failure (CHF) patients, the pulmonary 
vasculature may undergo reactive changes from chronic ele-
vation of the left ventricular filling pressure, resulting in se-
vere pulmonary hypertension with a reactive increase in 
pulmonary venous resistance (PVR) and transpulmonary 
gradient (TPG). This may reflect remodeling of the arterial 
wall due to abnormalities of the elastic fibers, intimal fibro-
sis, and medial hypertrophy [5]. In one study, CHF patients 
with higher pulmonary pressure had greater medial hyper-
trophy of their pulmonary arteries secondary to their pulmo-
nary venous hypertension [6]. Once pulmonary vascular dis-
ease progresses, the cardiac output is reduced from RV dys-
function and decreases the venous return to the left heart and 
with normalization of the LV filling pressure. At the time of 2    The Open Cardiovascular Medicine Journal, 2012, Volume 6  Afshar et al. 
presentation, these patients can have normal left heart filling 
pressure but significantly elevated pulmonary pressure, 
commonly misdiagnosed as PAH [2]. 
  Few studies have investigated the occurrence of unex-
plained pulmonary arterial hypertension in elderly patients. 
Heart failure with preserved EF is particularly common 
among the elderly. These patients may show a dispropor-
tionate degree of elevation in their left ventricular filling 
pressure (LVFP) [7]. Higher pulmonary vascular resistance 
in the elderly patients with heart failure but preserved ejec-
tion fraction (diastolic dysfunction) suggests that beyond the 
post-capillary contribution of pulmonary venous congestion, 
a pre-capillary component of pulmonary arterial hyperten-
sion occurs. Lam C, et al., describes the passive effect of 
long-standing pulmonary venous hypertension leading to 
pulmonary arterial remodeling and, subsequently, pulmonary 
arterial hypertension [8]. Up to a third of patients that de-
velop pulmonary venous hypertension will exhibit a reactive 
vasoconstriction of the small pulmonary arteries, resulting in 
increased PVR and a disproportionate increase in pulmonary 
artery systolic pressure (PASP) relative to the elevation of 
PCWP [4]. These are the patients that have been postulated 
to develop medial hypertrophy and intimal hyperplasia of the 
pulmonary arteries. We aim to describe the cohort of elderly 
patients with diastolic dysfunction and the degree of both 
pre-capillary pulmonary hypertension and post-capillary 
pulmonary hypertension utilizing right heart catheterization 
and echocardiography. 
MATERIALS AND METHODOLOGY 
  Chart reviews of 389 patients with pulmonary hyperten-
sion were performed between July 2003 and November 
2010. All patients had received a right heart catheterization 
to identify the etiology of their pulmonary hypertension by a 
pulmonary hypertension cardiology specialist at Rush Uni-
versity Medical Center in Chicago, Illinois, USA. PH was 
evaluated according to the guidelines of the American Col-
lege of Chest Physicians (ACCP) and World Health Organi-
zation (WHO). Chart review and data extraction occurred 
retrospectively after approval by the institutional review 
board of Rush University Medical Center. Using the Centric-
ity Cardiology database and Epic electronic medical record 
system at Rush University Medical Center, consecutive   
patients given a diagnosis of congestive heart failure or   
pulmonary hypertension after clinical evaluation including 
transthoracic echocardiography and undergoing right heart 
catheterization were evaluated. Three groups of patients 
were identified for comparison; systolic dysfunction, dia-
stolic dysfunction, and normal LV function with pulmonary 
arterial hypertension (PAH) (Fig. 1). Inclusion criteria were 
 
Fig. (1). Identification of Study Groups. Recruitment and identification of the study groups for patients with pulmonary hypertension who 
received a right heart catheterization. 
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pulmonary artery systolic pressure equal to or greater than 
35 for all groups and pulmonary capillary wedge pressure 
equal to or greater than 18 on right heart catheterization for 
group one and two. Group one were patients identified as 
heart failure with decreased ejection fraction (systolic dys-
function) with age greater than 65, ejection fraction less than 
50%, PCWP greater than 18, and PASP greater than 35 on 
right heart catheterization. Group two were identified as 
heart failure with preserved ejection fraction (diastolic dys-
function) and included patients with age greater than 65, 
preserved ejection fraction (EF greater than 50%), elevated 
PVR with PCWP greater than 18, and PASP greater than 35 
on right heart catheterization. Group three were patients with 
normal LV function and primary arterial hypertension (PAH) 
and included patients older than 18, PCWP less than 15, and 
elevated PASP greater than 35 on right heart catheterization. 
Group three patients were categorized using the Venice clas-
sification system [9]. Patients with EF less than 50% were 
included in group one and excluded from groups two and 
three. Patients with significant cardiac valvular disease, heart 
transplantation, non diagnostic heart catheterization, and 
congenital heart disease were excluded.  
Right-Heart Catheterization 
  Right-heart catheterization was performed by a flow-
directed pulmonary artery (PA) catheter using hemodynamic 
and fluoroscopic guidance with oxygen saturation measure-
ments in the wedged position. Measurements were obtained 
at end-expiration and averaged over three to five beats. Sys-
temic pulse pressure (systolic – diastolic BP), pulmonary 
arteriolar (vascular) resistance ([mean PA pressure – mean 
pulmonary capillary wedge pressure (PCWP)] ÷ cardiac in-
dex [CI]), and systemic vascular resistance ([mean arterial 
pressure – mean right atrial (RA) pressure] ÷ CI) [indexed] 
were calculated and expressed Wood units  meters squared. 
The transpulmonary pressure gradient (mean PA pressure – 
mean PCWP) was also calculated. Cardiac output by ther-
modilution and fick equation was measured.  
STATISTICAL ANALYSIS 
  The Chi-Square test was used to compare proportions of 
dichotomous variables in baseline characteristics between 
study groups. One-way Analysis of Variance (ANOVA) was 
used to compare continuous variables in baseline characteris-
tics and between study groups. Multivariate Analysis of Co-
variance (ANCOVA) test was used to compare PVRI, as a 
dependent variable, between group one and group two, ad-
justing for PCWP as a covariate. 
RESULTS 
  There are a total of 389 consecutive patients collected 
retrospectively between the three groups from July 2003 to 
November 2010. All patients received a diagnostic right 
heart catheterization and transthoracic echocardiogram. 
Group one patients with systolic dysfunction account for 
13.7% (n=59) of total patients. Group two with diastolic dys-
function account for 11.6% (n=50). Group three with normal 
left sided heart function and pulmonary arterial hypertension 
account for 65% (n=280) of the total patients. The majority 
of the patients in group three have a diagnosis of primary 
arterial pulmonary hypertension (n=114). Other etiologies in 
group three include chronic thromboembolic disease, sarcoi-
dosis, scleroderma, and connective tissue diseases. Sex dis-
tribution and total number of patients is displayed in Fig. (2). 
Groups one and two are well matched. Group three has sig-
nificantly more females. The average age in the elderly 
groups was 73 years old. As expected, group three com-
prised a younger population with an average age of 52 years 
old. Additional baseline characteristics are described in   
Table 1. Summary statistics for hemodynamic measurements 
 
Fig. (2). Patient Distribution and Sex Differences. Total number of patients in each study group and sex distribution. 
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obtained by right-heart catheterization and transthoracic 
echocardiogram are presented in Table 2.  
  There is no significant difference in PVRI between dia-
stolic dysfunction and systolic dysfunction groups. The mean 
Table 1.  Baseline Characteristics 
  Diastolic Dysfunction  Systolic Dysfunction  PAH with Normal LV  P Value 
AGE  74.6  72.4  52.4*  <0.001 
FEMALE  31 (52.5%)  26 (52.0%)  192 (68.7%)
*  0.01 
BMI  28.9  30.8  27.9*  0.04 
RACE:    White  39 (66.1%)  22 (44.0%)  163 (58.2%)  
                 African American  9 (15.3%)  19 (38%)  68 (24.3%)   
                Hispanic  2 (3.4%)  5 (10.0%)  19 (6.8%)   
                Other  9 (15.6%)  4 (8%)  30 (10.8%)   
* denotes statistical significant group. 
 
Table 2.  Study Group Outcomes Comparing Within Groups and Between Groups 
Diastolic  
HF 
Systolic  
HF 
PAH  
Normal LV 
Diastolic HF vs Systolic HF  Diastolic HF vs PAH normal LV 
 
Mean Value (SD) 
Mean Difference 
(95% CI) 
P value 
Mean Difference 
(95% CI) 
P value 
MAP 
(mmHg) 
 
90.1 (19) 
 
93.5 (23) 
 
93.4 (17) 
 
3.407 (-6.1 - 12.91) 
 
0.79 
 
3.3 (-4.2 to 10.8) 
 
0.66 
PASP 
(mmHg) 
 
57.8 (15) 
 
56.8 (16) 
 
67.6 (26) 
 
1.06 (-12.6 - 10.5) 
 
0.99 
 
9.7 (1.1 - 18.4) 
 
0.02 
mPA 
(mmHg) 
 
37.4 (10) 
 
38.5 (10) 
 
*42.6 (17) 
 
0.78 (-6.7 - 8.2) 
 
0.99 
 
4.9 (-0.67 - 10.5) 
 
0.03 
mPCWP 
(mmHg) 
 
25.5 (8) 
 
25.5 (8) 
 
*10.6 (5) 
 
0.08 (-3.0 - 3.1) 
 
1.0 
 
14.8 (12.5 - 17.1) 
 
<0.001 
mRA 
(mmHg) 
 
15.3 (9) 
 
13.0 (7) 
 
*8.4 (6) 
 
2.34 (-.81 - 5.5) 
 
0.22 
 
6.9 (4.6 - 9.2) 
 
<0.001 
LVEDP 
(mmHg) 
 
23.6 (10) 
 
27.0 (9) 
 
*13.9 (6) 
 
3.34 (-1.3 to 8.0) 
 
0.24 
 
9.71 (6.3 - 13.1) 
 
<0.001 
CI_TD 
(L/min) 
 
2.42 (0.7) 
 
1.96 (.4) 
 
2.67 (0.9) 
 
0.46 (-1.5 - 0.58) 
 
0.66 
 
0.26 (-0.17 - 1.6) 
 
0.67 
CI_Fick 
(L/min) 
 
2.15 (0.6) 
 
2.11 (0.7) 
 
*2.43 (0.8) 
 
0.04 (-0.35 - 0.43) 
 
0.99 
 
0.28 (-0.17 - 1.6) 
 
0.17 
SVR 
(Woods Units) 
 
19.2 (16) 
 
22.6 (17) 
 
20.5 (14) 
 
3.3 (-2.4 - 9.0) 
 
0.43 
 
1.2 (-5.8 - 3.4) 
 
0.90 
PVR 
(Woods Units) 
 
3.13 (3) 
 
3.52 (4) 
 
*8.45 (11) 
 
0.40 (-3.0 - 3.8) 
 
0.99 
 
5.32 (2.8 - 7.9) 
 
<0.001 
SVRI 
(Woods Units) 
 
36.9 (16) 
 
43.3 (17) 
 
37.8 (14) 
 
6.45 (-3.4 - 16.2) 
 
0.33 
 
0.95 (-7.4 - 9.3) 
 
0.99 
PVRI 
(Woods Units) 
 
5.12 (3) 
 
6.84 (4) 
 
*14.6 (11) 
 
1.7 (-4.1 - 7.5) 
 
0.87 
 
9.5 (5.0 - 14.0) 
 
<0.001 
EF (%) 
 
60.5 (5) 
 
*30 (11) 
 
59.6 (10) 
 
30.6 (25.2 - 36.1) 
 
<0.001 
 
0.88 (-3.4 - 5.2) 
 
0.96 
* denotes statistical significance with p value <0.05. MAP denotes Mean Arterial Pressure, CI confidence interval, SD standard deviation, PASP pulmonary artery systolic pressure, 
mPA mean pulmonary artery pressure, mPCWP mean pulmonary capillary wedge pressure, mRA mean right atrial pressure,  LVEDP left ventricular end diastolic pressure,  CI_TD 
cardiac index by thermodilution, SVR systemic vascular resistance, SVRI systemic vascular resistance index,  PVR pulmonary vascular resistance, PVRI pulmonary vascular resis-
tance index, EF ejection fraction by transthoracic echocardiogram. Pulmonary Hypertension in Elderly Patients with Diastolic Dysfunction  The Open Cardiovascular Medicine Journal, 2012, Volume 6    5 
difference in PVR between diastolic dysfunction and systolic 
dysfunction is not significant (p-value 0.99) at 0.40 
mmHg·min/L (95% CI -3.03 to 3.83) with similar left ven-
tricular end diastolic pressures that are also not significantly 
different (p-value 0.24) and mean difference of 3.38 mmHg 
(95% CI, -1.27 to 8.02). The measures in PAP are also not 
significant (p-value 0.99) between diastolic dysfunction and 
systolic dysfunction with mean difference of 1.06 mmHg 
(95% CI, -10.47 to 12.59). The mean difference in PVR be-
tween diastolic dysfunction and PAH with normal LV func-
tion is significant (p-value < 0.001) at 5.32 mmHg·min/L 
(95% CI, 2.75 to 7.88) and LVEDP is significantly lower,  
as expected, with mean difference of 9.71 mmHg (95%   
CI, 6.32 to 13.11). PVRI is significantly higher in PAH   
with normal LV function compared to both heart failure 
groups. For clinical perspective, Fig. (3) compares the 
hemodynamics shown to be significant. In setting of primary 
arterial hypertension with significantly elevated pre-capillary 
pressures, it is shown that PVR and PVRI is significantly 
higher.  
  The diastolic dysfunction group did not have higher PVR 
than the systolic dysfunction. Furthermore, mPCWP and 
LVEDP is significantly higher in the heart failure groups 
which correlate with elevated post-capillary pressures. Nev-
ertheless, when the elevated filling pressures measured by 
PCWP are adjusted for with ANCOVA analysis, diastolic 
dysfunction still did not show any disproportionate elevation 
in PVR compared to systolic dysfunction as hypothesized (p-
value 0.06). In fact, the mean PVR is more elevated in sys-
tolic dysfunction compared to diastolic dysfunction with 
means 3.13 mmHg·min/L and 3.52 mmHg·min/L, respec-
tively. The PAH group has significantly higher PVR than 
other groups with a mean of 8.45 mmHg·min/l (p < 0.001). 
The mPA did trend higher in the systolic dysfunction group 
in line with rising mPCWP as shown in Fig. (4) (p<0.001) 
with a standardized coefficient beta of 0.573.  
 
Fig. (3). Comparison Between Groups in Hemodynamics. Comparisons between groups in hemodynamic paramaters. All values with p 
value <0.001. Mean values plotted () with 95% confidence interval of upper bound and lower bound. 
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DISCUSSION 
  Diastolic heart failure is caused by inability to produce an 
adequate cardiac output at normal left ventricular filling 
pressure despite the presence of normal systolic function 
[10-13]. A normal forward cardiac output can only be main-
tained by a compensatory elevation of left ventricular filling 
pressure [14]. This state is associated with a marked increase 
in morbidity and all-cause mortality [15]. Progression in the 
degree of diastolic dysfunction is associated with worsening 
of the prognosis of heart failure patients [16, 17]. Further-
more, in elderly patients, there is a relationship between the 
degree of diastolic dysfunction and pulmonary arterial hy-
pertension [6]. Patients with pulmonary arterial hypertension 
can manifest with severe right ventricular hypertrophy,   
dilatation, and enhance ventricular interdependence and lead 
to elevated left ventricular diastolic pressures [7]. Bouchard 
et al. showed a close correlation between PASP and PCWP 
by echocardiography in 69 patients with normal systolic 
function (not all with HF) and concluded that PASP could be 
used as a surrogate of left ventricular filling pressure when 
pulmonary vascular resistance was assumed normal [18]. We 
also show similar results with elevation in mPA in concor-
dance with elevations in PCWP (Fig. 4). 
  In patients with aortic stenosis, most of whom had a 
normal ejection fraction, the severity of diastolic dysfunction 
rather than the severity of aortic stenosis correlated best with 
the severity of pulmonary hypertension and a significant 
number of patients developed severe pulmonary hyperten-
sion [19]. Similarly, in patients with heart failure and   
reduced ejection fraction (systolic heart failure), it was the 
severity of concomitant diastolic dysfunction rather than 
ejection fraction or cardiac output that correlated best with 
the severity of pulmonary hypertension [20]. Thus, diastolic 
dysfunction associated with valvular disease, reduced ejec-
tion fraction, or in isolation is the common mediator that 
results in chronic pulmonary venous hypertension and sec-
ondary pulmonary hypertension. It is therefore not unex-
pected that patients with diastolic heart failure will develop 
pulmonary hypertension as was demonstrated in this study. 
In addition, we did not show any evidence of a primary pul-
monary arteriopathy of late onset that may have concomitant 
(but unrelated) diastolic dysfunction related to their age as in 
previous studies [2]. Rather, the data support that there is no 
passive contribution of pulmonary venous hypertension to 
account for the increased PASP in diastolic dysfunction 
compared with elderly hypertensive subjects without overt 
heart failure that was shown by Lam et al., [8].  
  It seems reasonable to expect that elderly persons would 
be more susceptible to the development of pulmonary hyper-
tension as age related systemic vascular stiffening has been 
consistently reported and age-related pulmonary artery stiff-
ening may well occur [21-23]. This may reflect remodeling 
of the arterial wall due to abnormalities of the elastic fibers, 
intimal fibrosis, and medial hypertrophy [5]. However, the 
results of this study do not reveal such processes as evi-
denced by any disproportionate elevations in hemodynamics 
when compared to the systolic dysfunction group and PAH 
group.  
  It is more likely in our cohort of elderly patients, there 
was no etiology identified for secondary pulmonary hyper-
tension other than diastolic dysfunction and its associated 
elevated filling pressures as measured by PCWP. Therefore, 
 
Fig. (4). Correlation between mPAP and mPCWP in diastolic dysfunction. Correlation between mean pulmonary arterial pressure and 
mean pulmonary capillary wedge pressure in diastolic dysfunction demonstrated by right-heart catheterization. Measurements are in mmHg. Pulmonary Hypertension in Elderly Patients with Diastolic Dysfunction  The Open Cardiovascular Medicine Journal, 2012, Volume 6    7 
the increase in left ventricular free-wall stiffness led to pul-
monary venous hypertension and subsequently pulmonary 
arterial hypertension. The degree of pulmonary arterial hy-
pertension is not out of proportion to pulmonary venous hy-
pertension because it was similar to the patients with systolic 
dysfunction and still significantly less than patients with only 
pulmonary arterial hypertension (Fig. 3). Neumann et al. [6] 
showed a significant increase in PAP for any step-up in   
diastolic dysfunction stage
  similar to what we show in   
the present study (Fig. 4). However, some patients have a  
severely elevated PA pressure with only modestly elevated 
left-sided filling pressure. This class of patient often   
causes much confusion for treating physicians because of   
the uncertainty of whether or not these patients would   
benefit or be harmed by PAH selective therapy.  
  In the realm of cardiac transplantation, patients have 
shown to have graft failure with elevated TPG. It is assumed 
that a TPG of <15 mmHg is acceptable for transplantation, 
as the elevated PA pressure is in direct proportion with the 
elevated left-sided filling pressure [24]. An elevated TPG is 
associated with a very high incidence of post-operative right 
ventricular failure and death. Clinical studies have shown 
that a high PVR is also a risk factor for graft failure due to 
right heart failure early after cardiac transplantation [25]. 
Our patients did not have significantly elevated PVR so dia-
stolic dysfunction should be more seriously considered for 
cardiac transplantation. 
  This study is subject to the limitations of retrospective 
studies in which data are collected during the course of rou-
tine care. Nevertheless, the evaluation of these patients was 
fairly consistent. In addition this study may be susceptible to 
referral bias, and PCWP measurements can be erroneous. 
Yet, there is nothing to suggest that such errors are more 
frequent in elderly patients. While hemodynamic assessment 
of pulmonary vascular responsiveness is performed in many 
patients, these data are not reported because it was not con-
sistently performed nor performed in a standardized manner. 
The PVR, by using the cardiac output in its equation may be 
unreliable because of inherent inaccuracies in the measure-
ment of cardiac output by thermodilution, particularly at low 
cardiac outputs. The TPG is flow-independent and, thus, 
may better reflect resistance to flow across the pulmonary 
bed.  
  Age-related increases in arterial stiffening are worse   
in women than in men [21, 23, 26-29]. Interestingly, this 
study did not make the distinction in sex when evaluating 
hemodynamic parameters by right heart catheterization. 
Thus, elderly women who develop diastolic heart failure may 
be more prone to developing disproportionate pulmonary 
hypertension in response to chronic pulmonary venous   
hypertension associated with diastolic heart failure.  
  This retrospective study reveal there is no significant 
difference in PVR between diastolic dysfunction and systolic 
dysfunction groups when adjusted for PCWP. Instead the 
results are similar to previous studies that can show similar 
elevations between diastolic dysfunction and pulmonary hy-
pertension. Our results argue against any significant arterial 
remodeling that would lead to disproportionate pre-capillary 
hypertension, and implies that treatment should focus on 
lowering filling pressure rather than treating the pulmonary 
vascular tree. In addition, patients being considered for 
transplantation should not be limited by their diastolic   
dysfunction given no increase in PVR and post-operative 
mortality.  
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